Medical Equipment

Global Automated Drug Compounding Systems Market Expected To Reach $3.28 Billion By 2030 With 12% CAGR

May 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Automated Drug Compounding Systems Market From 2026 To 2030?

The automated drug compounding systems market size has seen substantial expansion in recent years. It is projected to expand from $1.85 billion in 2025 to $2.08 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.3%. This historical growth can be linked to the increased adoption of automated systems in hospital pharmacies, the growing necessity to reduce medication errors, an intensified concentration on sterile and precise drug preparation, the escalating workflow burden on pharmacy personnel, and the rising desire for compounding processes that save time.

The automated drug compounding systems market is projected for substantial expansion in the coming years. By 2030, its valuation is expected to reach $3.28 billion, demonstrating a compound annual growth rate (CAGR) of 12.0%. This anticipated growth during the forecast period is primarily driven by increased investment in healthcare automation, the expanding integration of software and automation tools, a growing demand for standardization in drug compounding, heightened emphasis on minimizing contamination risks, elevated hospital expenditures on automation infrastructure, and a rising imperative for enhanced operational efficiency within pharmacies. Significant developments expected over this period include progress in robotic-assisted drug compounding technologies, innovation in software integration for pharmacy management, incorporating artificial intelligence to mitigate errors in compounding processes, advancements in real-time monitoring and quality control systems, and novel approaches in automated sterile compounding techniques.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30527&type=smp

Which Drivers Are Supporting The Automated Drug Compounding Systems Market Growth?

The rising occurrence of chronic illnesses is anticipated to fuel the expansion of the automated drug compounding systems market moving forward. These long-term health conditions, which often progress slowly and include ailments like diabetes, heart disease, and arthritis, demand ongoing medical attention and lifestyle adjustments for symptom control and complication prevention. The increase in chronic diseases is largely linked to unhealthy habits such as poor diet, lack of physical activity, and smoking, elevating the risk of conditions like diabetes, heart disease, and obesity. Automated drug compounding systems contribute to chronic disease management by precisely preparing personalized medications for each patient, thus enhancing treatment accuracy and consistency, minimizing errors, and improving long-term therapeutic results. For example, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, representing an 18% increase from 3,065,825 cases in 2022. Consequently, the increasing prevalence of chronic diseases is a key driver for the growth of the automated drug compounding systems market. A lack of skilled pharmacy personnel is projected to boost the growth of the automated drug compounding systems market going forward. This scarcity refers to the limited availability of trained pharmacists and technicians required for the safe preparation and dispensing of medications in various healthcare settings. The increasing patient burden and the growing incidence of chronic diseases, which necessitate precise pharmaceutical care, contribute to this shortage of skilled staff. Automated drug compounding systems mitigate this reliance on expert pharmacy staff by enabling accurate, consistent, and efficient medication preparation with minimal human involvement, thereby reducing errors and lightening the workload for pharmacy teams. For instance, in August 2024, the National Center for Health Workforce Studies, a US-based health workforce research organization, indicated projections of a shortage of 4,980 pharmacists over the next 15 years through 2036, despite an expected overall demand growth for pharmacists of 3% from 2022 to 2032, raising concerns due to declining application trends. Thus, the shortage of skilled pharmacy staff is propelling the expansion of the automated drug compounding systems market.

What Are The Main Segments Within The Automated Drug Compounding Systems Market Segment Structure?

The automated drug compounding systems market covered in this report is segmented –

1) By Product: Robotic Compounding Systems, Automated Liquid Compounding Systems, Tablet And Capsule Dispensers, Injectable Compounding Robots, IV Admixture Systems, Oral Liquid Compounding Systems

2) By Component: Equipment, Software, Consumables, Services

3) By Technology: Robotic-Based Systems, Semi-Automated Systems, Gravimetric Dosing Systems, Volumetric Dosing Systems, Hybrid Dosing Systems

4) By End-User: Hospitals, Clinics, Retail Pharmacies, Compounding Pharmacies, Pharmaceutical Manufacturers

Subsegments:

1) By Robotic Compounding Systems: Fully Automated Sterile Compounding Robots, Hazardous Drug Compounding Robots, Non-Hazardous Drug Compounding Robots, High-Throughput Pharmacy Robots, Closed-System Robotic Compounding Units

2) By Automated Liquid Compounding Systems: Large-Volume Parenteral (LVP) Compounding Systems, Small-Volume Parenteral (SVP) Compounding Systems, Multi-Drug Liquid Compounding Units, Volumetric And Gravimetric Liquid Compounding Systems, Pediatric Liquid Dosing Compounding Systems

3) By Tablet and Capsule Dispensers: Automated Tablet Counting Dispensers, Unit-Dose Packaging Systems, Multi-Dose Blister Dispensing Units, Capsule Filling and Dispensing Systems, High-Speed Pharmacy Dispensing Robots

4) By Injectable Compounding Robots: Chemotherapy Drug Compounding Robots, TPN (Total Parenteral Nutrition) Compounding Robots, High-Precision Syringe Preparation Robots, Sterile Injectable Filling Robots, Hazardous Injectable Handling Systems

5) By IV Admixture Systems: Automated IV Bag Filling Systems, IV Nutrition (TPN) Admixture Systems, IV Antibiotic Admixture Devices, Pharmacy Cleanroom IV Automation Units, Closed-System IV Compounding Systems

6) By Oral Liquid Compounding Systems: Pediatric Oral Liquid Compounding Machines, Flavoring & Suspension Mixing Systems, Multi-Ingredient Oral Liquid Compounding Units, Gravimetric Oral Solution Compounding Systems, Low-Volume Oral Dosing Compounding Systems

Which Trends Are Expected To Impact The Automated Drug Compounding Systems Market?

Major companies within the automated drug compounding systems market are directing their efforts towards creating sophisticated systems, particularly total parenteral nutrition (TPN) automation systems, with the goal of improving the accuracy, safety, and efficiency in preparing personalized intravenous formulations. A total parenteral nutrition (TPN) automation system is defined as a compounding platform that not only automates the mixing and dispensing of total parenteral nutrition (TPN) solutions but also integrates prescription validation and workflow management tools, which collectively work to reduce human error and ensure sterile, high-quality preparation. For instance, in May 2025, MediServ Co. Ltd. launched the APEX TPN Compounding System in Riyadh, heralding a new era of precision and automation for parenteral nutrition workflows. The system, demonstrated with its EasyComp integration software, refines the total parenteral nutrition (TPN) process by linking validated prescriptions through to sterile, accurate compounding, thereby streamlining pharmacy operations and diminishing manual tasks.

Who Are The Companies Participating In The Automated Drug Compounding Systems Market?

Major companies operating in the automated drug compounding systems market are Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical Inc., Omnicell Inc., Eckert & Ziegler SE, Swisslog Healthcare AG, EQUASHIELD Medical Ltd., Trasis S.A., Loccioni Group S.p.A., ARxIUM Inc., Comecer S.p.A., Tema Sinergie S.p.A., Epic Medical Pte. Ltd., IBA Radiopharma Solutions S.A., Steriline S.r.l., Elysia-Raytest GmbH, Curifylabs OY, Kapsam Health Solutions Pvt. Ltd.

Get The Full Automated Drug Compounding Systems Market Report:

https://www.thebusinessresearchcompany.com/report/automated-drug-compounding-systems-market-report

Which Region Dominates The Automated Drug Compounding Systems Market By Market Share?

North America was the largest region in the automated drug compounding Systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated drug compounding systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Automated Drug Compounding Systems Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=30527&type=smp

Browse Through More Reports Similar to the Global Automated Drug Compounding Systems Market 2026, By The Business Research Company

Automated Compounding Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

Lab Automation In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

drug formulation global market report

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795